Geneva Capital Management LLC Decreases Position in STERIS plc (NYSE:STE)

Geneva Capital Management LLC lessened its holdings in STERIS plc (NYSE:STE) by 11.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 105,975 shares of the medical equipment provider’s stock after selling 13,842 shares during the period. Geneva Capital Management LLC owned approximately 0.11% of STERIS worth $21,784,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Ashton Thomas Securities LLC purchased a new stake in shares of STERIS during the 3rd quarter worth $25,000. Human Investing LLC purchased a new stake in shares of STERIS during the 4th quarter worth $31,000. Anfield Capital Management LLC lifted its position in shares of STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after purchasing an additional 91 shares during the last quarter. Central Pacific Bank Trust Division lifted its position in shares of STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 76 shares during the last quarter. Finally, Manchester Capital Management LLC lifted its position in shares of STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 137 shares during the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

STERIS Trading Up 0.8 %

NYSE STE opened at $227.51 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The firm has a market cap of $22.35 billion, a PE ratio of 48.30 and a beta of 0.84. STERIS plc has a one year low of $197.82 and a one year high of $248.24. The firm’s fifty day moving average is $215.99 and its two-hundred day moving average is $222.79.

STERIS (NYSE:STE) last posted its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Analysts expect that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be paid a $0.57 dividend. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.00%. STERIS’s dividend payout ratio is presently 48.41%.

Wall Street Analysts Forecast Growth

STE has been the subject of several recent analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Friday, November 8th. Stephens reissued an “overweight” rating and issued a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. Piper Sandler boosted their price target on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Finally, JMP Securities reissued a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a research report on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.